Fetal abdominal circumference in the second trimester and prediction of small for gestational age at birth.
Infants that are small for gestational age (SGA) at birth are at increased risk for morbidity and mortality. Unfortunately, the antenatal prediction of SGA is suboptimal. We sought to: 1. examine the association between second trimester fetal abdominal circumference < 10% (2T-AClag) with SGA and other gestational and neonatal adverse outcomes; 2. assess 2T-AClag as a predictor of SGA. Retrospective study of 212 singleton gestations with 2T-AClag on routine ultrasound between 18-24 weeks. The study group was compared to 424 gestations without 2T-AClag for maternal characteristics as well as pregnancy and neonatal adverse outcomes. A multivariate logistic regression was used to determine the predictive value of 2T-AClag for SGA, adjusting for maternal and pregnancy characteristics. The screening model accuracy was assessed through receiver operating characteristic (ROC) curves. Fetal growth restriction (FGR) was defined as an estimated fetal weight (EFW) less than the 10th percentile. Gestations with 2T-AClag had higher rates of SGA (35.7 versus 11.6%, p < 0.0001), FGR (17 versus 1.7%, p < 0.0001), pregnancy induced hypertension (31.1 versus 17%, p < 0.0001), preeclampsia (14.6 versus 7.8%, 0 = 0.01), abnormal umbilical artery Doppler (30 versus 5.1%, p < 0.0001), indicated preterm birth (5.7 versus 1.9%, p = 0.01), primary cesarean birth (29.6 versus 20.1%, p = 0.01) and NICU admission (12.9 versus 6.4%, p = 0.009). After adjusting for maternal and gestational risk factors, 2T-AClag remained an independent risk factor for SGA (OR 4.53, 95%CI 2.91-7.05, p < 0.0001) and FGR (OR 11.57, 95%CI 5.02-26.65, p < 0.0001). The inclusion of 2T-AClag in a regression model with traditional risk factors, significantly improved the model's predictability for SGA and FGR (area under ROC curve increased from 0.618 to 0.723 and 0.653-0.819, respectively, p < 0.0001). Second trimester abdominal circumference (AC) lag is associated with an increased risk of SGA, FGR and other adverse outcomes. The inclusion of 2T-AClag in a screening model for prediction of SGA and FGR may improve the identification of this at-risk group and assist in customizing surveillance plans.